A 44-year-old Caucasian male affected by SCZ presented wide fluctuations in his leukocyte counts documented over a seven-year period. The medical history was significant for co-morbid chronic obstructive pulmonary disease (COPD) and diabetes mellitus type 2 (DMT 2). Apart from clozapine, his pharmacotherapy comprised atenolol, atorvastatin and alprazolam.
A 51-year-old Caucasian male affected by SCZ, presented wide fluctuations in leukocytes over a 5-year period on clozapine therapy. Along with clozapine, his pharmacotherapy comprised zuclopenthixol, haloperidol, flurazepam, gabapentin, choline.